JUN and cancer: Once activated, ERK1/2 is transferred to the nucleus where it regulates the activity of various transcription factors (such as Elk1, c-Fos, c-Jun, and c-Myc) through phosphorylation, thereby contributing to tumorigenesis or cancer growth [32].